First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy

Despite evidence implicating transcription factors, including STAT3, in oncogenesis, these proteins have been regarded as “undruggable”. We developed a decoy targeting STAT3 and performed a phase 0 trial. Expression levels of STAT3 target genes were decreased in the head and neck cancers following i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sen, Malabika, Thomas, Sufi. M., Kim, Seungwon, Yeh, Joanne I., Ferris, Robert L., Johnson, Jonas T., Duvvuri, Umamaheswar, Lee, Jessica, Sahu, Nivedita, Joyce, Sonali, Freilino, Maria L., Shi, Haibin, Li, Changyou, Ly, Danith, Rapireddy, Srinivas, Etter, Jonathan P., Li, Pui-Kai, Wang, Lin, Chiosea, Simion, Seethala, Raja R., Gooding, William. E., Chen, Xiaomin, Kaminski, Naftali, Pandit, Kusum, Johnson, Daniel. E., Grandis, Jennifer R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3668699/
https://ncbi.nlm.nih.gov/pubmed/22719020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0191
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky